Chee Conley
- SEC CIK
- 0001883804
No open-market purchases or sales filed in the past year.
Current role at each company
- SYRS Syros Pharmaceuticals, Inc.President & CEOas of Nov 20, 2024
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Chee Conley as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 20, 2024 (view filing)5:00 PM ET | Nov 18 | 2 days | Chee ConleyPresident & CEO | SSale | −134.8K | $0.1998 | −$26.9K | −100.0%0 after | |
| Sep 12, 2024 (view filing) | Sep 10-11 | 2 days | Chee ConleyPresident & CEO | PPurchase | +100.0K | $1.61 | +$161.0K | +444.4%122.5K after | 2 lots |